| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6957040cd6075e8cdf2616604541e93f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2019-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ffea186e88da1b9d8c867a133ffac35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70036fd7339e18454980b6c54d63085e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38e04ab40718793dc869a9634858e1a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db6bd01b01f02564f4041c2d787f4847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dccbfba51e423fdd157a923810b77a23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d918ad51d1c4d1a1b4e39a557bc40d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2d018a5bbc11f3064f152439063aca7 |
| publicationDate |
2021-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3827005-A1 |
| titleOfInvention |
Pyridopyrimidines as histamine h4-receptor inhibitors |
| abstract |
The invention relates to compounds of formula (I) or pharmaceutically acceptable salts or solvates thereof, to pharmaceutical compositions comprising them and to their use in the treatment and/or prevention of diseases or disorders mediated by histamine H4 receptor. |
| priorityDate |
2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |